Pharmacokinetics of ganciclovir for prevention of cytomegalovirus infection in a lung transplant recipient on veno-arterial extracorporeal membrane oxygenation: A case report and literature review
- 2 June 2025
- journal article
- case report
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (8) , 102745
Abstract
No abstract availableKeywords
Funding Information
- Kyoto University
- Japan Society for the Promotion of Science (24H02626, 24H02659)
This publication has 17 references indexed in Scilit:
- Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO: a case reportInternational Journal of Antimicrobial Agents, 2021
- A Review on Drug‐Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation ApproachesClinical Pharmacology in Drug Development, 2020
- Paediatric ganciclovir dosing in extracorporeal membrane oxygenation: Is standard dosing good enough?Journal of Clinical Pharmacy and Therapeutics, 2019
- Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patientsJournal of Clinical Pharmacy and Therapeutics, 2017
- Cytomegalovirus infection in living-donor and cadaveric lung transplantations†Interactive CardioVascular and Thoracic Surgery, 2017
- Extracorporeal Membrane Oxygenation—Hemostatic ComplicationsTransfusion Medicine Reviews, 2015
- Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenationJournal of Critical Care, 2012
- Tacrolimus whole blood concentrations correlate closely to side‐effects in renal transplant recipientsBritish Journal of Clinical Pharmacology, 1999
- Sensitivity of Clinical Isolates of Human Cytomegalovirus to 9-(1,3-Dihydroxy-2-Prop.oxymethyl)GuanineThe Journal of Infectious Diseases, 1985
- The Physiologic Role of Pulsatile and Nonpulsatile Blood FlowArchives of Surgery, 1967